The changes in hepatic glucose production (R.), tissue glucose disposal (Rd), and plasma glucose and insulin concentration that took place over a 16-h period from 10 to 2 p.m. were documented in 14 individuals; 8 with non-insulin-dependent diabetes mellitus (NIDDM) and 6 with normal glucose tolerance. Values for R. were higher than normal in patients with NIDDM at 10 p.m. (4.73±0.41 vs. 3.51±0.36 mg/kg per min P < 0.001), but fell at a much faster rate throughout the night than that seen in normal subjects. As a consequence, the difference between R. in normal individuals and patients with NIDDM progressively narrowed, and by 2 p.m, had ceased to exist (1.75±0.61 vs. 1.67±0.47 mg/kg per min, P = NS).
normal subjects this occurs throughout the day in response to meals, and postprandial hyperglycemia is clearly a situation in which Ra exceeds Rd. However, this condition is quite transitory, within a short time Ra and Rd are again equal, and euglycemia exists for most of the daily 24-h period in individuals with normal glucose tolerance. In contrast, hyperglycemia is continuously present in patients with non-insulin-dependent diabetes mellitus (NIDDM), and questions remain as to the relative contribution of changes in R. and Rd to this state of abnormal physiological regulation. On the one hand, there is considerable evidence that Rd is markedly reduced in patients with NIDDM as compared with normal patients when measured during periods of physiological hyperinsulinemia (1, 2) . On the other hand, after an overnight fast Rd can be greater than normal in patients with NIDDM with significant fasting hyperglycemia (1) . R. has also been shown to be increased in such patients (3) (4) (5) (6) (7) (8) (9) and statistically significant correlations have been documented between measurement of Ra and fasting plasma glucose concentration (3, 4, (7) (8) (9) . Based upon such considerations, it has been suggested that fasting hyperglycemia in NIDDM is due to an increase in Ra, whereas the defect in Rd accounts for postprandial hyperglycemia (3, 4, 9, 10) . This generalization is primarily based upon studies performed in the morning, after an overnight fast, in which Ra is measured over an -2-h period, i.e., from 8 to 10 a.m., and the observed value is correlated with plasma glucose concentration at 8 a.m. We were concerned about the results of studies carried out in this manner for two reasons. In the first place, the results of such experiments offer a relatively static view of nature, and do not provide any insight into the ongoing relationship that exists between Ra and Rd. Secondly, we were concerned that 2 h was not long enough for tracer equilibrium to occur in patients with NIDDM and an expanded glucose pool size, thereby preventing accurate estimates of Ra (11) . Indeed, we have indicated that it takes at least 4 h for tracer equilibrium to occur in patients with NIDDM (12) . The present study was initiated to address both of these issues, and involved measurement of plasma glucose and insulin concentrations, Ra and Rd in normal subjects and patients with NIDDM continuously over a 16-h 
Methods
Eight patients with NIDDM and severe fasting hyperglycemia (> 250 mg/dl) and six normal individuals volunteered for this study. The two groups were similar in terms of age and degree of obesity (see Table I ), and were in good general health with the exception ofdiabetes. They all gave informed consent and were admitted to the General Clinical Research Center at Stanford University Medical Center 24 h before the commencement of the study. All subjects were fed an isocaloric (35 kcal/kg) diet, containing (as percentage of total calories) 17% protein, 40% fat, and 43% carbohydrate, and each meal had this relative content of nutrients. Meals were eaten at 0800, 1200, and 1800 hours, and contained 20, 40, and 40%, respectively, of the day's total caloric intake.
To Aliquots of plasma obtained at 30-min intervals were analyzed for plasma glucose (13) and insulin (14) concentration. In addition, aliquots were precipitated with Ba(OH)2 and ZnSO4 (15), and glucose and radioactivity were measured in the protein-free supernatant. Glucose specific activity was then determined, and the rate of glucose appearance (Ra) was calculated, using the non-steady state equations of Steele (16, 17) . Rd was calculated from Ra, taking into account the change in plasma glucose concentration and the rate ofurinary glucose loss. On two occasions the overnight studies were repeated, with the addition of an intravenous injection of 1 mg of glucagon administered at midnight, 4 h after the start ofthe tracer infusion. Plasma radioactivity (in counts per minute per milliliters) was essentially identical on both nights, indicating that radiolabeled glucose was not being taken up and released to a degree significant enough to modify the experimental measurements.
Two-way analysis of variance (ANOVA) was used to evaluate differences in values of the two groups at various time points ( 18) using the Statistical Analysis System (SAS Institute, Inc., Cary, NC) on a VAX750 computer. When there was significant interaction between time and group, the difference at the individual time point was evaluated by the adjusted t test ofBonferroni (19) . Correlations between the experimental and the glucose levels were assessed by linear regressions, using Clinfo (Bolt, Beranek, and Newman, Inc., Cambridge, MA) on the VAX750. Data are expressed as mean ±SEM. fell progressively throughout the 16-h period of study in patients with NIDDM, significant hyperglycemia was still present in these individuals at the termination of the study. These data emphasize the progressive fall in plasma glucose concentration from 10 to 2 p.m. in patients with NIDDM, in contrast to the relatively stable glucose values in the individuals with normal oral glucose tolerance. In addition, this graph emphasizes the fact that plasma glucose concentration remained markedly elevated in patients with NIDDM throughout the study.
The change in plasma insulin concentration from 10 to 2 p.m. is illustrated in Fig. 2 . Insulin concentrations were higher in the normal subjects when the study was initiated at 10 p.m., but fell rapidly from 10 p.m. to 2 a.m. Thus, plasma insulin concentrations were essentially identical in both groups for the majority of the 16-h period.
The data in Fig. 3 show mean (±SEM) values for Ra in the two groups from 10 to 2 p.m. These results indicate that Ra was higher than normal in patients with NIDDM at 10 p.m., and that the magnitude of the difference between the two groups is greatest at this time point. Values for Ra fell with time in both groups, but the rate and magnitude of decline in Ra was greatMean (±SEM) plasma glucose values at hourly intervals from 10 to 2 p.m. are shown in Fig. 1 , and were significantly higher in patients with NIDDM throughout the 16-h period (two-way ANOVA, P < 0.001). Although plasma glucose concentration est in patients with NIDDM. As a result, the values for the two groups became more and more similar. R. values were significantly greater (two-way ANOVA, P < 0.001) in patients with NIDDM from 10 to 2 p.m. In addition, there was a significant interaction between Ra and time (P < 0.001). Given the evidence of interaction, differences between Ra values of the two groups at each time point were evaluated by Bonferroni adjusted t test (19) . When this was done, Ra was significantly higher than normal in patients with NIDDM until 10 a.m. (P < 0.001-0.05). No differences were seen from 10 a.m. to 2 p.m. Rd values in the two groups taken at hourly intervals throughout the experimental period are shown in Fig. 4 , and when they were analyzed over the entire time period they were similar (two-way ANOVA). However, Rd was higher in patients with NIDDM when the study began at 10 p.m., but lower in these same individuals when the measurements finished at 2 p.m. This evidence of interaction between Rd and time was confirmed statistically (two-way ANOVA, P < 0.05). When Rd at individual time points was compared by the adjusted t test ofBonferroni, Rd was higher in NIDDM at 10 p.m. 
Discussion
The results presented in this paper provide a different view of the relationship between R. and magnitude of hyperglycemia in patients with NIDDM than that which seems to be generally held at this time. Several publications have documented a correlation between fasting plasma glucose concentration (measured at -8 a.m.) and Ra (measured from 8 to 10 a.m.) (3, 4, (7) (8) (9) , and concluded that hepatic overproduction of glucose is primarily responsible for maintenance of the enlarged plasma glucose pool in patients with NIDDM (9, 10). The data in Fig.  1 shows that the plasma glucose pool size was approximately three times greater than normal at 2 p.m. Since values for Ra were similar at this same time in patients with NIDDM and normal individuals (Fig. 3 
II
continuously from 10 to 2 p.m. in patients with NIDDM, eventually becoming equal to normal. This fall in Ra was paralleled by a reduction in plasma insulin concentration, and normal values for Ra were achieved when insulin levels were equal to normal. The decline in R. that took place from 10 to 2 p.m. was also associated with a fall in plasma glucose concentration of over 100 mg/dl. Thus, the lowest value for Ra coincided with the lowest plasma insulin and glucose concentrations. In other words, the combined suppressive effects of insulin and glucose were at their maximum when Ra was the highest in patients with NIDDM, and Ra fell to normal over a time frame in which the inhibitory effects of insulin and glucose were steadily declining. One possible explanation for these findings is that substrate load plays an important role in the regulation of Ra. The data in Figs. 3 and 4 show that the fall in Rd parallels the decline in Ra, and both are associated with a reduction in plasma glucose concentration. Hyperglycemia can compensate for resistance to insulin-stimulated glucose uptake by increasing Rd (20) , and the fact that Rd fell in conjunction with the decrease in plasma glucose is consistent with this formulation. Furthermore, Rd, which was higher than normal in NIDDM at the start of our observations, was lower at the end. If a proportion of the excess glucose uptake seen in NIDDM from 10 p.m. to 10 a.m. was recycled back to the liver, in the form of lactate, for example, it could help explain the elevated Ra at that point. In this regard, it is noteworthy to remember that plasma FFA levels are also higher in patients with NIDDM (21, 22) , and that elevated FFA concentration has been associated with an increase in hepatic glucose production (8, 22, 23) . As plasma glucose concentration fell, Rd would be reduced, less lactate recycling would occur, and R. would decline. This formulation raises the possibility that elevated values for Ra in patients with NIDDM may result from increased substrate flux to the liver. Whether or not this hypothesis is correct will depend upon additional measurements. However, at the moment it seems consistent with the experimental data presented. Attention throughout this discussion has focussed on regulation ofRa in patients with NIDDM. However, in conclusion, some thought should be given to the implication these results have for regulation of plasma glucose pool size. It can be seen from Fig. I that patients with NIDDM were still severely hyperglycemic at the end of the period of measurement, despite having values for Ra that were similar to normal for the preceding several hours. These findings indicate that tissue glucose uptake was extremely abnormal. Indeed, tissue glucose uptake is not the only reason why the glucose pool size fell overnight, and urinary glucose excretion averaged -0.75 mg/kg per min over the last 12 h. Since Rd only averaged -1.5 mg/kg per min over the same time period, -1/3 of the fall in plasma glucose pool size was due to urine loss. As plasma glucose pool size approaches 180 mg/dl, glucose loss via the kidney ceases, and the decline in plasma glucose pool size will be even slower.
Indeed, it takes 72 h for plasma glucose pool size to reach normal levels in patients with NIDDM who are undergoing a total fast (24) . Thus, the observed decrease in tissue glucose disposal must play an enormous role in the expanded glucose pool size ofpatients with NIDDM. Given this defect, relatively small increases in Ra will exceed the ability of an individual to maintain euglycemia. The fact that this increment in Ra may be essential for the transition from a marginal to a marked increase in glucose pool size should not obscure the magnitude of the defect in tissue glucose disposal in NIDDM, nor the essential role played by this abnormality in maintenance ofthe hyperglycemic state.
